/AEMD
AEMD Stock - Aethlon Medical, Inc.
Healthcare|Medical - DevicesNASDAQ
$2.86+1.06%
+$0.03 (+1.06%) • Dec 19
45
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.54
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.15
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AEMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.83 – $2.89
TARGET (TP)$3.29
STOP LOSS$2.63
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.64
52W High$84.80
52W Low$2.83
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | $574,245 | $294,165 | $659,104 |
| Gross Profit | N/A | N/A | $574,245 | $294,165 | $659,104 |
| Gross Margin | N/A | N/A | 100.0% | 100.0% | 100.0% |
| Operating Income | $-9,341,365 | $-12,636,568 | $-11,898,638 | $-10,420,885 | $-7,891,499 |
| Net Income | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 | $-7,886,709 |
| Net Margin | N/A | N/A | -2094.9% | -3540.9% | -1196.6% |
| EPS | $-85.80 | $-48.60 | $-58.60 | $-70.60 | $-65.20 |
Company Overview
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
0%
Hold / Neutral
1
100%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
0 Bullish1 Neutral/Bearish
Price Targets
$2
Average Target
↓ 47.6% Downside
Now
$2
Low
$2
Average
$2
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 7th 2025 | H.C. Wainwright | Resumed | Neutral | $1.5 |
Earnings History & Surprises
AEMDBeat Rate
47%
Last 19 quarters
Avg Surprise
-50.2%
EPS vs Estimate
Beats / Misses
9/9
1 met exactly
Latest EPS
$-3.74
Q4 2025
EPS Surprise History
Q1 24
-11.4%
$-1.37vs$-1.23
Q2 24
+22.9%
$-0.91vs$-1.18
Q3 24
+22.7%
$-0.34vs$-0.44
Q4 24
0.0%
$-0.20vs$-0.20
Q1 25
+40.9%
$-0.13vs$-0.22
Q2 25
-642.9%
$-7.28vs$-0.98
Q3 25
-25.0%
$-8.50vs$-6.80
Q4 25
-120.0%
$-3.74vs$-1.70
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 11, 2026 | $-2.01 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-1.70 | $-3.74 | -120.0% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-6.80 | $-8.50 | -25.0% | ✗ MISS |
Q2 2025 | Jun 26, 2025 | $-0.98 | $-7.28 | -642.9% | ✗ MISS |
Q1 2025 | Feb 12, 2025 | $-0.22 | $-0.13 | +40.9% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-0.20 | $-0.20 | 0.0% | = MET |
Q3 2024 | Aug 14, 2024 | $-0.44 | $-0.34 | +22.7% | ✓ BEAT |
Q2 2024 | Jun 27, 2024 | $-1.18 | $-0.91 | +22.9% | ✓ BEAT |
Q1 2024 | Feb 14, 2024 | $-1.23 | $-1.37 | -11.4% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-1.35 | $-1.22 | +9.6% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-1.20 | $-1.30 | -8.3% | ✗ MISS |
Q2 2023 | Jun 28, 2023 | $-1.60 | $-1.10 | +31.3% | ✓ BEAT |
Q1 2023 | Feb 13, 2023 | $-0.40 | $-1.20 | -200.0% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-2.30 | $-1.80 | +21.7% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-2.40 | $-1.90 | +20.8% | ✓ BEAT |
Q2 2022 | Jun 28, 2022 | $-1.20 | $-2.50 | -108.3% | ✗ MISS |
Q1 2022 | Feb 14, 2022 | $-1.30 | $-1.60 | -23.1% | ✗ MISS |
Q4 2021 | Nov 9, 2021 | $-1.50 | $-1.30 | +13.3% | ✓ BEAT |
Q3 2021 | Aug 9, 2021 | $-1.30 | $-1.60 | -23.1% | ✗ MISS |
Q2 2021 | Jun 24, 2021 | $-2.00 | $-1.50 | +25.0% | ✓ BEAT |
Latest News
Aethlon Medical Announces $3.3M Gross Proceeds In Private Placement Of Shares And Warrants Priced At $4.03
📈 PositiveBenzinga•Dec 5, 2025, 02:19 PM•Also:
Aethlon Medical Announces Publication Of Pre-Clinical Long COVID Study On bioRxiv
➖ NeutralBenzinga•Dec 2, 2025, 01:26 PM
Aethlon Medical shares are trading higher. The company reported Q2 financial results.
📈 PositiveBenzinga•Nov 13, 2025, 02:15 PM
Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate
📉 NegativeBenzinga•Nov 12, 2025, 09:16 PM
Aethlon Medical Regains Nasdaq Compliance
📈 PositiveBenzinga•Nov 6, 2025, 02:22 PM
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
➖ NeutralBenzinga•Oct 20, 2025, 12:55 PM
Aethlon Medical shares are trading lower after the company announced a 1-for-10 reverse stock spilt.
📉 NegativeBenzinga•Oct 16, 2025, 05:17 PM
Aethlon Medical Authorizes 1-For-10 Reverse Stock Split
📉 NegativeBenzinga•Oct 16, 2025, 01:23 PM
Aethlon Medical Reports Early Signals From Hemopurifier Trial In Cancer Patients, Showing Immune And Molecular Shifts In First Cohort
➖ NeutralBenzinga•Oct 7, 2025, 12:13 PM
Aethlon Medical shares are trading lower after the company announced a $4.5 million public offering.
📉 NegativeBenzinga•Sep 4, 2025, 03:13 PM
Aethlon Medical prices $4.5M public offering with 5-Year warrants; shares down 47%
📉 NegativeSeeking Alpha•Sep 4, 2025, 01:46 PM
Aethlon Medical Announces $4.5M Equity Offering; 5M Shares and Warrants Priced At $0.90/Shr
📉 NegativeBenzinga•Sep 4, 2025, 01:18 PM
Aethlon Medical shares are trading higher. The company late Wednesday filed for an offering of common stock and accompanying warrants.
➖ NeutralBenzinga•Aug 21, 2025, 05:00 PM
Aethlon Medical Files For Offering Of Common Stock And Accompanying Warrants; Size Not Disclosed
📉 NegativeBenzinga•Aug 20, 2025, 09:21 PM
Aethlon Medical Cuts Loss in Fiscal Q1
📈 PositiveThe Motley Fool•Aug 13, 2025, 09:45 PM
Frequently Asked Questions about AEMD
What is AEMD's current stock price?
Aethlon Medical, Inc. (AEMD) is currently trading at $2.86 per share. The stock has moved +1.06% today.
What is the analyst price target for AEMD?
No analyst price targets are currently available for this stock.
What sector is Aethlon Medical, Inc. in?
Aethlon Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is AEMD's market cap?
Aethlon Medical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does AEMD pay dividends?
No, Aethlon Medical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADAP
Adaptimmune Therapeutics plc
$0.05
Mkt Cap: $0.0B
ALUR
Allurion Technologies Inc.
$1.47
Mkt Cap: $0.0B
CODX
Co-Diagnostics, Inc.
$0.26
Mkt Cap: $0.0B
ERNA
Ernexa Therapeutics Inc.
$1.31
Mkt Cap: $0.0B
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$1.02
Mkt Cap: $0.0B
LNAI
Lunai Bioworks Inc.
$1.05
Mkt Cap: $0.0B
NVNO
enVVeno Medical Corporation
$0.32
Mkt Cap: $0.0B
TNON
Tenon Medical, Inc.
$1.10
Mkt Cap: $0.0B
VVOS
Vivos Therapeutics, Inc.
$1.97
Mkt Cap: $0.0B
XAIR
Beyond Air, Inc.
$0.91
Mkt Cap: $0.0B
Explore stocks similar to AEMD for comparison